Evidence map›Paper›PMID 35700514›Full record

ArticleBiomaterials science2022

Inter-donor variability of extracellular matrix production in long-term cultures of human fibroblasts.

Fabien Kawecki, Maude Gluais, Stéphane Claverol, Nathalie Dusserre, Todd McAllister, Nicolas L'Heureux

Open access · hybridAbstract read
In one paragraph

Article in Biomaterials science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fabien KaweckiUniv. Bordeaux, Inserm, BioTis, UMR1026, F-33000 Bordeaux, France. nicolas.lheureux@inserm.fr.ORCID http://orcid.org/0000-0002-1409-623X
Maude GluaisUniv. Bordeaux, Inserm, BioTis, UMR1026, F-33000 Bordeaux, France. nicolas.lheureux@inserm.fr.
Stéphane ClaverolCentre de Génomique Fonctionnelle, Plateforme Protéome, University of Bordeaux, F-33000, Bordeaux, France.
Nathalie DusserreUniv. Bordeaux, Inserm, BioTis, UMR1026, F-33000 Bordeaux, France. nicolas.lheureux@inserm.fr.ORCID http://orcid.org/0000-0002-4699-3365
Todd McAllisterAccess Medical Research, Loxahatchee, Florida, FL, USA.
Nicolas L'HeureuxUniv. Bordeaux, Inserm, BioTis, UMR1026, F-33000 Bordeaux, France. nicolas.lheureux@inserm.fr.ORCID http://orcid.org/0000-0001-8602-3948
Université de Bordeaux · FRAccess to Wholistic and Productive Living Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several tissue engineering approaches are based on the ability of mesenchymal cells to endogenously synthesize an extracellular matrix (ECM)

Indexed as

Extracellular MatrixFibroblastsBiocompatible MaterialsExtracellular Matrix ProteinsHumansHydroxyprolineTissue EngineeringBiocompatible MaterialsExtracellular Matrix ProteinsHydroxyproline

Identifiers

PMID35700514
PMCPMC9275472
OpenAlexW4282960373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.